D.C. Diagnosis

D.C. Diagnosis Sarah Owermohle

The end of an era for the FDA’s longtime drug chief

D.C. Diagnosis Rachel Cohrs Zhang

Bernie Sanders’ showdown with pharma CEOs is coming to a head

D.C. Diagnosis Sarah Owermohle

STAT Plus: White House pharmacy under the microscope

D.C. Diagnosis Rachel Cohrs Zhang

Will Congress get any health policy done this year?

D.C. Diagnosis Sarah Owermohle

STAT Plus: Health care negotiations on Capitol Hill are clear as mud

D.C. Diagnosis Sarah Owermohle

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

D.C. Diagnosis Sarah Owermohle

At JPM, how much health policy talk should we expect?

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: An ugly fight over care for the poor in Texas

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Diabetes ‘epidemic’ gets a Senate hearing

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: What health policies could hitch a ride on a spending bill?

D.C. Diagnosis Rachel Cohrs Zhang

Medicare eligibility is tripping up the GOP presidential candidates

D.C. Diagnosis Sarah Owermohle

STAT Plus: Sen. Bernie Sanders moves toward another hearing with pharma CEOs

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Breaking down House Speaker Mike Johnson’s health care plan

D.C. Diagnosis Rachel Cohrs Zhang

The future of health care in the House

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Did you have Obamacare on your GOP debate bingo card?

D.C. Diagnosis Sarah Owermohle

STAT Plus: Will a government shutdown stall Medicare drug price negotiations?

D.C. Diagnosis Rachel Cohrs Zhang

Senate HELP on collision course

D.C. Diagnosis Sarah Owermohle

STAT Plus: Is there a path forward for PEPFAR?

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: A new House health package & hospitals’ new site-neutral talking points

D.C. Diagnosis Sarah Owermohle

Setting the September calendar in health care

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis

D.C. Diagnosis Sarah Owermohle

What RFK Jr.’s popularity says about GOP health priorities, Lilly CEO’s big bet, and the looming cereal wars

D.C. Diagnosis Sarah Owermohle

FDA budget battles, prisons’ sobering Covid response & BIO’s CEO search is on

D.C. Diagnosis Rachel Cohrs Zhang

After nine months, an update on NIH’s long Covid research

Health Lev Facher

Biden administration unveils dashboard to track nonfatal drug overdoses

D.C. Diagnosis Sarah Owermohle

Health funding battles, a nutrition policy overhaul, and two CBD developments

D.C. Diagnosis Rachel Cohrs Zhang

It’s not looking good for Covid and monkeypox funding, problems ahead for PrEP, & the not-so-historic Juul settlement

D.C. Diagnosis Elissa Welle

Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep

D.C. Diagnosis Edward Chen

A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox